Intratumoral methotrexate kinetics in a patient with intracranial anaplastic ependymoma

Pediatric Blood and Cancer

Volumn 43, Issue 1, 2004, Pages 78-80

  Geis, T ^a   Peters, O ^a   Friedrich, M ^b   Dranert E ^c   Wolff, Johannes E A ^a,d,e  

^a Barmherzige Bruder Regensburg   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Hospital Barmherzige Bruder Regensburg   (Germany)

^d UNIVERSITY OF CALGARY   (Canada)

^e Klinik St Hedwig   (Germany)

Author keywords

Childhood cancer; Ependymoma; Methotrexate; Pharmacokinetics

Indexed keywords

METHOTREXATE;

AREA UNDER THE CURVE; ARTICLE; CASE REPORT; CHILDHOOD CANCER; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG INFUSION; DRUG MEGADOSE; DRUG RETENTION; DRUG TUMOR LEVEL; EPENDYMOMA; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; INFANT; INTRACRANIAL ANAPLASTIC EPENDYMOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUNCTURE; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN NEOPLASMS; EPENDYMOMA; FEMALE; HUMANS; INFANT; METHOTREXATE; TISSUE DISTRIBUTION;

EID: 2942531022     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20048     Document Type: Article

References (10)

1. Chatelut E, Roche H, Plusquellec Y, et al. Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in children. J Pharm Sci 1991;80:730-734.
2. Muller M, Brunner M, Schmid R, et al. Interstitial methotrexate kinetics in primary breast cancer lesions. Cancer Res 1998;58: 2982-2985.
3. Porpaczy P, Schmidbauer CP, Georgopoulos A, Endler AT. Pharmacokinetics of high-dose methotrexate in dogs. An experimental model with diffusion chambers. Cancer Chemother Pharmacol 1983;11:172-176.
4. Kuhl J, Bode U, Deinlein F, et al. Postoperative chemotherapy in infants with medulloblastoma: Final results of HIT-SKK 92 German Pediatric Brain Tumor Study Group. Med Pediatr Oncol 2002;39:245.
5. Morikawa N, Mori T, Kawashima H, et al. Methotrexate concentration in cerebrospinal fluid of the space created by tumor removal. Biol Pharm Bull 2000;23:774-777.
6. Tator CH. Retention of tritiated methotrexate in a transplantable mouse glioma. Cancer Res 1976;36:3058-3066.
7. Jolivet J, Cowan KH, Curt GA, et al. The pharmacology and clinical use of methotrexate. N Engl J Med 1983;309:1094-1104.
8. Muller M, Bockenheimer J, Zellenberg U, et al. Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: A study in breast cancer patients. Breast Cancer Res Treat 2000;60:211-217.
9. Needle MN, Goldwein JW, Grass J, et al. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 1997;80:341-347.
10. Weitman SD, Frazier KM, Kamen BA. The folate receptor in central nervous system malignancies of childhood. J Neurooncol 1994;21:107-112.